Following a discussion on how to monitor patients with Clostridium difficile for a response to treatment, Lawrence J. Brandt, MD; Erik Dubberke, MD; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, remark on the risk of recurrence and management of patients’ post therapy and how to proceed if recurrence occurs.
